Tenofovir Disoproxil Fumarate
These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001
b43a3cae-059e-4af8-8fcf-07a597e57f0d
HUMAN PRESCRIPTION DRUG LABEL
Oct 27, 2022
Qilu Pharmaceutical Co., Ltd.
DUNS: 653878256
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Tenofovir Disoproxil Fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Tenofovir Disoproxil Fumarate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Tenofovir Disoproxil Fumarate
Product Details
FDA regulatory identification and product classification information